Performance of mesenchymal cell-scaffold constructs in human oral reconstructive surgery: a systematic review by Cristalli, Maria Paola et al.
Volume 6 • Issue 2 • 1000225
J Biotechnol Biomater
ISSN: 2155-952X JBTBM, an open access journal 
Research Article Open Access
Jo
ur
na
l o
f B
iot
echn
ology & Biom
aterials
ISSN: 2155-952X
Cristalli et al., J Biotechnol Biomater 2016, 6:2
http://dx.doi.org/10.4172/2155-952X.1000225
Journal of Biotechnology & Biomaterials
*Corresponding author: Susanna Annibali, Department of Oral and Maxillo Facial 
Sciences, "Sapienza" University of Rome, 6, Caserta St., 00161, Rome, Italy, Tel: 
+39 06 49976651; Fax +39 06 44230811; E-mail: susanna.annibali@uniroma1.it 
Received April 07, 2016; Accepted April 29, 2016; Published May 06, 2016
Citation: Cristalli MP, Marini R, Pranno N, Patini R, La Monaca G, et al. 
(2016) Performance of Mesenchymal Cell-Scaffold Constructs in Human Oral 
Reconstructive Surgery: A Systematic Review. J Biotechnol Biomater 6: 225. 
doi:10.4172/2155-952X.1000225
Copyright: © 2016 Cristalli MP, et al. This is an open-access article distributed 
under the terms of the Creative Commons Attribution License, which permits 
unrestricted use, distribution, and reproduction in any medium, provided the 
original author and source are credited.
Performance of Mesenchymal Cell-Scaffold Constructs in Human Oral 
Reconstructive Surgery: A Systematic Review
Maria Paola Cristalli1, Roberta Marini2, Nicola Pranno2, Romeo Patini3, Gerardo La Monaca4 and Susanna Annibali2* 
1Department of Biotechnology and Medical Surgical Sciences, “Sapienza” University of Rome, Italy 
2Department of Oral and Maxillo-facial Sciences, “Sapienza” University of Rome, Italy
3Dentistry Unit of Head and Neck clinical Area, Catholic University of Sacred Heart, Rome, Italy
4Department of Sense Organs, “Sapienza” University of Rome, Italy 
Abstract
Background: Different sources of cultured cells combined with different scaffolds (allogenic, xenogeneic, 
alloplastic or composite materials) have been tested extensively in vitro and in preclinical animal studies, but there 
have been only a few clinical trials involving humans.
Aim: This study reviewed all of the English language literature published between January 1990 and December 
2015 to assess the histological performance of different mesenchymal cell-scaffold constructs used for bone 
regeneration in human oral reconstructive procedures.
Methods: An electronic search of the MEDLINE and Cochrane Central Register of Controlled Trials databases 
complemented by manual searching was conducted to identify studies involving histological evaluation of 
mesenchymal cell-scaffold constructs in human oral surgical procedures. The methodological quality of randomized 
controlled clinical trials and controlled clinical trials was assessed using the Cochrane Collaboration tool for assessing 
the risk of bias. Heterogeneity was assessed using Review Manager software. Considering the heterogeneity, the 
data collected were reported by descriptive methods and a meta-analysis was applied only to the articles that reported 
the same outcome measures. The articles were classified and described based on the material scaffolds used.
Results: The search identified 1030 titles and 287 abstracts. Full-text analysis was performed for 32 articles, 
revealing 14 studies that fulfilled the inclusion criteria. Three randomized controlled clinical trials were identified as 
potentially eligible for inclusion in a meta-analysis. The studies were grouped according to the scaffold materials 
used: bone allograft (three studies), polyglycolic-polylactic scaffold (four studies), collagen sponge (two studies), 
and bovine bone matrix (five studies). The stem cells used in these studies had been sourced from the iliac crest, 
periosteum, dental pulp and intraoral sites.
Conclusions: The very small amount of available data makes it impossible to draw any firm conclusions 
regarding the increase in bone formation in human oral reconstructive procedures when using graft materials 
engineered with autogenous stem cells.
Keywords: Mesenchymal stem cell; Tissue scaffold; Bone regeneration; 
Tissue engineering; Ridge augmentation; Maxillary sinus lift
Introduction
Critical-size bony defects represent a major clinical challenge 
in oral reconstructive surgery because they jeopardize physiological 
bone healing to an extent that may prevent complete regeneration. 
In achieving bone repair of oral tissue lost due to congenital defects, 
degenerative disease, infections, cysts, trauma or surgical procedures, 
autogenous bone grafting still remains the gold standard due to its 
osteogenic, osteoinductive and osteoconductive properties [1,2]. 
However, the use of autogenous bone has significant drawbacks 
such as a limited intraoral supply, the requirement for an additional 
operation under general anaesthesia in cases of an extraoral donor site, 
the tendency for partial resorption, and donor-site discomfort and 
morbidity. For these reasons many different biomaterials have been 
investigated for use in bone regeneration over the years, but all of them 
have demonstrated poor clinical performance when used alone.
An important opportunity is offered by tissue-engineering 
approaches, which involve the use of adequately differentiated cells, and 
provide the ability to produce extracellular matrix with mineralizing 
capability, the presence of communications and interactions between 
cells and matrix, the production and release of growth factors in the 
regeneration area, and the presence of a scaffold, which mimics the 
three-dimensional (3D) structure of the bone [3].
In this field, different sources of cultured cells combined with 
different scaffolds (allogenic, xenogeneic, alloplastic or composite 
materials) are being extensively tested in vitro and in preclinical animal 
studies, but only a few clinical trials have been performed in humans.
The present study reviewed all English-language literature published 
between January 1990 and December 2015 with the aim of determining 
the histological performance of different mesenchymal cell-scaffold 
constructs used for bone regeneration in human oral reconstructive 
procedures.
Material and Methods
The protocol used in this systematic review was based on the 
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PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-
Analyses) statement [4,5].
Focus question
This study attempted to address the following question: what is 
the clinical and histological performance of different mesenchymal 
cell-scaffold constructs used for bone regeneration in oral surgical 
procedures in humans?
Search strategy
A comprehensive and systematic electronic search in the Cochrane 
Central Register of Controlled Trials (CENTRAL) and MEDLINE via 
OVID was carried out for articles published in the English language 
between January 1990 and December 2015. Only human studies were 
selected. The following combination of the MeSH terms was used: “stem 
cells”, “sinus floor augmentation”, “alveolar ridge augmentation”, “oral 
surgery”, “maxillary sinus”, “oral surgery procedures” and “jaw diseases”.
A supplementary manual search was performed of the following 
peer-reviewed journals for articles published between January 2005 and 
December 2015: Clinical Oral Implant Research, Journal of Oral and 
Maxillofacial Surgery, Clinical Implant Dentistry and Related Research, 
British Journal of Oral and Maxillofacial Surgery, Tissue Engineering 
and Biomaterials. In addition, the bibliographies of all selected articles 
were checked so that other potentially relevant studies were also 
included in the analysis.
Selection criteria
Only studies involving histological evaluations of mesenchymal 
cell-scaffold constructs in human oral surgical procedures were 
considered. The following exclusion criteria were applied:
−	 Case report.
−	 Case series with fewer than 10 surgical sites.
−	 Letters and narrative or retrospective reviews.
−	 Studies without histological results.
−	 Periodontal or maxillofacial procedures.
−	 The use of mesenchymal stromal cells (MSCs) in general 
surgery. 
−	 In vitro and animal studies.
In addition, in cases of duplicate publications, the article with the 
most recent data was preferred.
Study selection 
The screening procedure of all titles and abstracts retrieved by the 
electronic and manual searches was carried out by two of the authors 
independently. To avoid excluding potentially relevant articles, articles 
whose abstracts described unclear results were included in the full-text 
analysis. 
The full texts of all potentially relevant articles were obtained, and 
eligible studies were identified by two reviewers. Any disagreement was 
checked by an independent reviewer and resolved through discussion. 
Data collection
Two reviewers used specially designed data extraction forms to 
independently extract the following information from the included 
studies: year of publication, type of study, characteristics of the 
scaffold, source of stem cells, patient’s sample, surgical procedures 
and clinical, radiographic and histological data related to changes in 
mineralized bone. Any disagreement between them was discussed, and 
a third review author was consulted where necessary. The articles were 
classified and described based on the scaffold material utilized.
Quality assessment
A methodological quality assessment was performed in the 
randomized controlled clinical trials (RCTs) and in the controlled 
clinical trials using the Cochrane Collaboration tool for assessing the 
risk of bias.
Assessment of heterogeneity
Heterogeneity was assessed using Review Manager (RevMan) 
software [6]. The significance of any discrepancies in the estimates of the 
treatment effects from the different trials was assessed using Cochran’s 
test for heterogeneity and the I2 statistic. The chi-square test was used 
to evaluate the percentage of total variation across studies that were due 
to heterogeneity rather than chance. Heterogeneity would have been 
considered to be significant if the probability value was less than 0.1.
Data synthesis
A descriptive method was applied to report the data of selected 
articles, considering the heterogeneity in the study design, stem-cell 
population, surgical procedures, study period, methods for assessing 
the quality and quantity of regenerated bone, and the time required to 
perform the histological evaluation.
A meta-analysis was applied only to articles that reported the same 
outcome measures for the bovine bone matrix (BBM) scaffold. The 
mean differences were combined for continuous data using either fixed-
effects models or, if the presence of heterogeneity between the studies 
was established, random-effects models. However, if there was a high 
degree of heterogeneity, the data were explored further to determine if 
they should be excluded from the meta-analysis [7].
Mean ± standard deviation values were calculated using the method 
outlined in Pudar-Hozo et al. [8]. If sufficient data were available, point 
estimates and 95% confidence intervals for the specific interventions 
were calculated.
Results
Study selection
The electronic search identified 1017 studies, while an additional 
13 were collected from the manual search and 9 from the references of 
selected articles and reviews. The full text of 32 of these 1039 articles 
was screened. Fourteen studies fulfilled the inclusion criteria, while 
19 were excluded (Table  1) from the descriptive analysis and 2 from 
the meta-analysis (Figure 1). The 14 included studies comprised 3 case 
series, 7 case-control studies, 1 retrospective cohort study and 3 RCTs. 
The 3 RCTs were identified as potentially eligible for inclusion in the 
meta-analysis.
Study characteristics 
The augmentation procedure was a sinus lift in 12 studies [9-
20]. In one study [21], bone grafting was performed in a mandibular 
defect after extracting the third molar. Another study [22] applied 
ridge augmentation and sinus lifting in the posterior maxilla and ridge 
augmentation in the anterior maxilla. The stem-cell populations had 
been harvested from the iliac crest (bone marrow stem cells) [11,13,15-
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17,20,22], periosteum (mesenchymal stem cells) [9,10,14,18], dental 
pulp (dental pulp stem cells) [21] and intraoral sites (autogenous 
culture-expanded bone cells) [12,19]. 
Bone biopsies were performed at different time periods after surgery: 
3-4 months [9,13-17,19,20], 6 months [10-12,18], 8 months [22] or 3 
years [21]. Histological findings were reported in terms of percentages 
of newly formed bone (NB) [10-13,15-17,19] or as descriptive results 
[9,14,18,20-22]. Radiographic evaluations were performed using 
computed tomography (CT) in seven studies [11-13,15,17,18,22] and 
by orthopantomography (OPT) in three studies [9,14,21].
The studies were divided into four groups based on the scaffold 
materials used: bone allograft [15,20,22], polyglycolic-polylactic 
(PLGA) scaffold [9,12,14,18], collagen sponge [10,21] and BBM 
[11,13,16,17,19]. The main characteristics of the included studies are 
summarized in Table 2.
Bone allograft 
Bone allografts from tissue banks were used in three studies 
[15,20,22]. In a case-series study, Cerruti et al. [22] treated 32 patients 
aged 45–83 years (median age 65 years) with 32 anterior or posterior 
maxillary defects to increase the amount of bone available for placing 
the dental implants. All procedures were performed using iliac bone 
allografts with autologous mononuclear cells obtained from the iliac 
crest or sternum bone-marrow aspirate, and platelet-rich plasma (PRP). 
Bone biopsies and CT were performed at 8 months after surgery, and 
the implants were placed in the grafted area.
Thirty of the 32 bone grafts (94.7%) were well-integrated, and all of 
the placed implants were functional and exhibited almost no bone loss 
after 2-4 years. Radiographic examinations revealed that the amount of 
bone was at least 6 mm in width and 10 mm in height, peaking at 14 
mm in the anterior maxilla; in the posterior maxilla the width increase 
Figure 1: Flowchart of the selection of the studies for the review.
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was not significant, and the bone height ranged between 9 mm and 15 
mm. The bone biopsies reportedly showed “lines of bone formation and 
the presence of osteoblasts around the bone trabecula” [22].
In a case-control study, Gonshor et al. [15] compared bone 
formation in a two-step maxillary sinus lift procedure using either an 
allograft cellular bone matrix containing MSCs and osteoprogenitors 
(Osteocel, ACE Surgical and NuVasive) in 14 test sites, or conventional 
allografts (alloOss, ACE Surgical) in 7 control sites. CT scans were 
performed prior to and immediately following surgery and at the time 
of implant placement. Bone biopsy samples were harvested after 3.7 ± 
0.6 months, during implant insertion. Histomorphometric evaluations 
revealed that the amounts of both vital and residual bone differed 
significantly between the two grafts. The amount of vital bone was 32.5 
± 6.8% for the allograft cellular bone graft and 18.3 ± 10.6% for the 
conventional allograft, and the amounts of residual graft were 4.9 ± 
2.4% and 25.8 ± 13.4% in the test and control allografts, respectively.
Bertolai et al. [20] evaluated bone regeneration in 40 two-stage 
sinus augmentation procedures performed bilaterally in 20 patients 
(mean age 55.2 years). In accordance with the split-mouth design, the 
test side of each patient was grafted with freeze-dried bone allograft 
(FDBA) absorbed with MSCs, harvesting from the iliac crest and PRP, 
Reference Rationale for exclusion
MacAllister et al. [30] < 10 surgical sites
Ueda et al. 2005 [31] No histological evaluations
Ueda et al. 2008 [32] No histological evaluations
D'Aquino et al. [23] Redundant publication (Giuliani et al. [21])
Yamada et al. [33] Case report
Smiler et al. [34] < 10 surgical sites
Kim et al. [35] Case report
Soltan et al. [36] < 10 surgical sites
Zizelmann et al. [27] No histological evaluations
Schmelziesen et al. [37] < 10 surgical sites
Beaumont et al. [38] < 10 surgical sites
Hibi et al. [39] Case report
Behnia et al. [40] < 10 samples
Yamada et al. [41] No histological evaluations
Shayesteh et al. [42] < 10 surgical sites
Montesani et al. [43] Case report
Strietzel et al. [44] Case report
Behnia et al. [45] < 10 surgical sites
Meijer et al. [46] < 10 surgical sites
Table 1: Reasons of excluded studies.
First author, year Study design Scaffold Stem cell Sample size (control/ test) Surgical procedure Rx Evaluation Bone biopsy
Schimming et 
al. [9] Case series PLGA
MSCs from 
periosteum 27 Sinus lift OPT after 3 months. After 3 months.
Springer et al. [10] Case-control Collagen sponge/BBM
MSCs from 
periosteum/ ACBCs 
from tuberosity
8/12 Sinus lift No
After 6 months in test 
sites and 8 months in 
control sites.
Filho Cerruti et 
al. [22] Case series
Bone allografts 
block 
hBMSCs from iliac 
crest + PRP 32
Anterior-posterior 
augmentation + sinus 
lift
CT before and 8 months 
after surgery. After 8 months.
Fuerst et al. [11] Case series BBM ACBCs from iliac crest 22 Sinus lift
CT after sinus lift, after 
implant placement and after 
implant uncovery.
After 6 months.
Mangano et al. 
[12]
Split-mouth 
case-control PLGA
ACBCs from the
posterior area of 
the mandible
5/5 Sinus lift CT before and 6 months after surgery. After 6 months.
Sauerbier et al. 
[13] Case-control BBM
hBMSCs from iliac 
crest 6/12 Sinus lift CT cone beam After 3 months.
Voss et al. [14] Case-control PLGA MSCs from periosteum 63/50 Sinus lift
OPT before surgery, 
before and after implant 
placement, after the final 
prosthesis.
After 6 months.
Gonshor et al. [15] Case-control
Allograft 
cellular bone 
matrix
hBMSCs 21 Sinus lift CT before and 3-4 months after surgery. After 3-4 months.
Rickert et al. [16] RCT BBM hBMSCs from iliac crest 12/12 Sinus lift No After 3-4 months.
Sauerbier et al. 
[17] RCT BBM
hBMSCs from iliac 
crest 11/34 Sinus lift
CT before and after c3.5 
months. After 3.5 months
Trautvetter et al. 
[18]
Retrospective 
cohort PLGA
MSCs from 
periosteum 17 Sinus lift
CT before, after 4,12,24 
and 60 months after 
surgery. After 6 months.
Hermund et al. [19] RCT BBM ACBCs from tuberosity 10/10 Sinus lift No After 4 months.
Giuliani et al. [21] Case-control Collagen 
sponge
hDPSCs 7/7 Socket grafting OPT before, 6 months, 1 and 3 years after surgery. After 3 years.
Bertolai et al. [20] Split-mouth case control
Freeze-dried 
bone allograft 
hBMSCs from iliac 
crest + PRP 20/20 Sinus lift No After 3 months.
PLGA = Polyglycolic–polylactic scaffold; MSCs = Mesenchymal stem cells; PRP = Platelet-rich plasma; OPT = Orthopantomography; BBM = Bovine bone matrix; ACBCs = 
Autogenous culture-expanded bone cells; hBMSCs = Human bone marrow-derived mesenchymal stem cells; CT = Computer Tomography; RCT = Randomized controlled 
trial; hDPSCs = Human dental pulp stem cells
Table 2: Characteristics of the included studies.
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and the control side was grafted with FDBA alone. Bone biopsies were 
performed after 3 months at the time of implant placement. Histological 
analyses revealed that the control samples showed substantial 
persistence of the FDBA particles, separated from the trabeculae of NB 
bone by large amounts of fibrous connective tissue; in the test samples, 
the graft was adjacent to or embedded within the NB, without the 
interposition of fibrous connective tissue. 
Polyglycolic-polylactic scaffold
Four articles had reported on the use of PLGA scaffold in the sinus 
lifting procedures. In a non-randomized clinical study, Shimming et 
al. [9] carried out 41 sinus lift procedures (17 one-stage and 24 two-
stage procedures) in 27 patients (45-57 years old) using PLGA fleece 
(Ethisorb®, Ethicon, Norderstedt, Germany), and used cultures of 
osteogenic cells deriving from mandibular periosteum. In all cases of 
the one-step procedure, radiologic (OPT) and clinical assessments were 
performed 3 months after surgery, which revealed excellent results in 
66.6% of the patients. CT was carried out in selected cases. Bone biopsy 
samples were obtained at the time of implant placement, but only in 16 
of the two-stage procedures, because in 8 patients no NB was detected 
at clinical inspections performed 3 months after augmentation. 
Histological analyses revealed mineralized trabecular bone, and the 
presence of residual biomaterial between trabeculae and osteocytes in 
lacunae within the bone substance.
In a split-mouth case-control study, Mangano et al. [12] compared 
the outcomes of 10 two-stage sinus augmentations that were performed 
bilaterally in 5 patients (45-65 years old) using autogenous osteoblasts 
seeded on PLGA scaffold (Oral Bone®, BioTissue Technologies, 
Freiburg, Germany) in the test sites and blocks of coral-derived porous 
hydroxyapatite (Biocoral, Novaxa Spa, Milan, Italy) in the control 
sites. CT data were acquired at baseline and at 6 months after surgery. 
Bone biopsies were performed at the time of implant placement after 
a healing period of 6 months. A radiographic comparison of the test 
and control sites showed vertical bone gains of 6.47 ± 1.39  mm and 
9.14 ± 1.19  mm, respectively. Bone biopsies performed at both sites 
showed the presence of mature bone with compact and cancellous 
areas. Histomorphometrically the biopsy samples obtained from 
engineered bone revealed 37.32 ± 19.59% bone spaces and 62.67 ± 
27.71% medullar spaces. Sinus grafted with hydroxyapatite comprised 
54.65 ± 21.17% NB, 17.56 ± 5.03% medullar spaces and 27.78 ± 16.31% 
remaining material particles. Biopsies performed at both sites showed 
the presence of mature bone with compact and cancellous areas. From 
these results the authors concluded that PLGA scaffold plus autogenous 
osteoblasts showed a poor efficacy in promoting cellular activity and 
bone regeneration.
In a non-randomized clinical study, Voss et al. [14] evaluated bone 
regeneration in sinus lift procedures comparing the use of periosteum 
stem cells and PLGA scaffold (Ethisorb®, Ethicon) in 35 patients (35-
69 years old) and autogenous iliac bone in 41 patients (38-73 years 
old). Among the 35 patients in the study group, 15 underwent a 
bilateral sinus lift procedure (50 test sites) and 17 received a two-stage 
procedure. In the control group, 22 patients underwent augmentation 
of both sinuses (65 control sites). Bone biopsy samples were obtained 
after a healing period of 15 weeks in selected two-stage cases during 
the insertion of the implants. Radiologic evaluations were performed 
using OPT before surgery, before and after implant placement, and after 
the final prosthetic restoration. The clinical and radiologic follow-up 
lasted at least 24 months. Biopsy specimens obtained from 7 patients 
in the study group showed mineralized trabecular bone with remnants 
of biomaterial and the presence of osteocytes within the bony lacunae, 
while in 10 patients (16 sinuses) the grafts had acquired a connective-
tissue-like consistency, and so an additional augmentation procedure 
with autologous bone and bone substitutes was required. No patient 
in the control group required a second operation, and only 1 implant 
failed, compared to 11 in the study group. The rate of complications 
(sinusitis, abscesses, loss of augmented material and loss of implants) 
was higher in the study group than in the control group. 
Trautvetter et al. [18] evaluated the use of the same polymer 
scaffold in a 5-year retrospective cohort. Ten patients were treated 
with 17 one-step sinus lifts (bilaterally in 7 patients) using autologous 
tissue-engineered periosteal bone grafting (Oral Bone®, BioTissue 
Technologies). Radiologic examinations (OPT and CT) and clinical 
evaluations were carried out preoperatively and at 4, 12, 24 and 60 
months post-surgery. Bone biopsy specimens were obtained in two 
cases after 6 months. The median bone height, measured in 27 regions 
of interest, increased from 6.9 mm, preoperatively, to 16.0 mm at the 
4-month follow-up, and then remained significantly greater (P<0.05, 
median 14.2 mm) during the 5-year observation period. Histological 
examinations performed at 6 months confirmed the formation of full 
grown/mature bone, with osteocytic cells and/or osteocytes embedded 
in the trabecular bone lacunae and osteoblasts actively forming NB. No 
remnants of the biomaterial, no formation of connective tissue and no 
signs of necrosis or cell apoptosis were seen.
Collagen sponge
Only two studies had used collagen as a scaffold material [10,21]. 
Springer et al. [10] reported on a comparative study of three regenerative 
approaches for the two-stage sinus lift procedure. In group  1 (test 
group), 12 sinuses in 8 patients (51.4-65.2 years old) were augmented 
with periosteum-derived stem cells seeded on 4 sheets of collagen 
matrix (Lyostyp, Braun); in group 2A (control group), 3 sinuses in 2 
patients (43 and 56 years old) were regenerated with a combination of 
cultured autogenous osteoblasts (taken from the maxillary tuberosity) 
and BBM blocks (Bio-Oss®, Geistlich Pharma, Wolhusen, Switzerland); 
and in group 2B (another control group), 5 sinuses in 3 patients (46-58 
years old) were treated with BBM blocks alone. Bone biopsy samples 
were obtained during implant placement at 6 months in group 1 and 
at 8 months in groups 2A and 2B. None of the implants were lost and 
no adverse effects were seen throughout the observation period: 12–38 
months in group 1 and approximately 7 years in groups 2A and 2B. In 
group 1 the core biopsies showed vital woven, partly lamellar bone, and 
small remnants of collagen matrix and an NB density of 38% (range 
30.5-51%), which did not differ significantly from that in group 2A 
(range 32–43%).
Giuliani et al. [21] assessed the stability and quality of regenerated 
bone in bilateral post-extractive third molar sockets, filled with equine 
collagen I sponge (Gingistat, Vebas, San Giuliano Milanese, Italy) with 
(test site) or without (control site) third molar dental pulp stem cells, 
at 3 years after grafting. The sample (7 patients aged 24-40 years) was 
the same as that in a previously published study [23]. Clinical and 
radiologic evaluations were performed, and bone biopsy samples were 
obtained from all patients at 3 months after augmentation, using the 
replacement jigs used in the previous study. 
The clinical assessment showed no signs of infection or morbidity 
in the surgical areas, and periodontal probing gains of 6.3 ± 2.1 mm and 
4.5 ± 1.4 mm at the test and control sites, respectively. The completeness 
of regeneration and the improved vertical bone height in the test sites 
relative to the control sites were confirmed by OPT. Histological 
analyses revealed that the collagen sponge used as a scaffold was always 
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completely reabsorbed, and that the regenerated bone at the test sites 
was characterized by a compacted architecture, with Haversian canals 
surrounded by several lamellae and osteocyte-containing lacunae. In 
contrast, the bone at the control sites was characterized by a cancellous 
(spongy) structure, with interrupted lamellae surrounding numerous 
large marrow-filled spaces arranged in a more-or-less regular pattern. 
Bovine bone matrix scaffold
BBM was used as a scaffold in five studies: two [11,13] fulfilled the 
criteria for inclusion in the systematic review, and three [16,17,19] were 
RCTs and could be included in the meta-analysis. 
In a prospective clinical study, Fuerst et al. [11] described the healing 
process in 22 two-stage sinus lift procedures applied to 12 patients (age 
56.2 ± 9.3 years) with a mixture of bovine bone mineral granules (Bio-
Oss®, Geistlich Pharma) and autogenous bone cells harvested from the 
anterior iliac crest (9 patients) or from the chin (3 patients). CT scans 
were performed after sinus grafting (CT1), after implant placement 
(CT2) and after uncovering the implant (CT3). Bone biopsy samples 
were obtained after 6 months during implant insertion. The post-
operative healing period was uneventful, but 3 of the 82 placed implants 
were removed due to implant mobility after uncovering the implant. 
The graft volume was 2218.4 ± 660.9 mm3 at the time of CT1, 1694.0 
± 470.4 mm3 at CT2 and 1347.9 ± 376.3 mm3 at CT3, with significant 
progressive decreases of 23.62%, 20.45%, and 39.24% from CT1 to CT3. 
Histologically the BBM and bone were unevenly distributed: NB was 
woven and vital, and some of the BBM granules were surrounded by NB 
and some by connective tissue. A histomorphometric analysis revealed 
that NB and BBM were 17.9 ± 4.6% and 19.4 ± 10.1%, respectively, and 
that 26.8 ± 13.1% of the BBM surface was in contact with NB.
Sauerbier et al. [13] compared the NB formation in the two-stage 
sinus lift procedure using BBM granules (Bio-Oss®, Geistlich Pharma) 
and bone-marrow-aspirate-derived mesenchymal stem cells harvested 
from the pelvis, and processed by a FICOLL (Sigma, St Louis, MO, 
USA) or BMAC (Bone Marrow Procedure Pack, Harvest Technologies 
Corporation, Plymouth, MA, USA) method. 
In total, 18 sinuses (6 in the FICOLL group and 12 in the BMAC 
group) were augmented in 11 patients (4 in the FICOLL group and 
7 in the BMAC group). In a second-stage procedure performed after 
3 months, bone biopsy samples were obtained and implants were 
placed. Of the 50 implants inserted (17 FICOLL and 33 BMCA), 
only 1 implant in the BMCA group failed before applying prosthetic 
loading. Histological specimens from the FICOLL and BMCA groups 
showed similar results: the newly formed osseous lamellae appeared as 
vital bone tissue containing osteocytes inside the bone lacunae, which 
connected the BBM particles and stabilized the graft complex. The 
histomorphometric analysis produced the following estimated values: 
19.9% NB for BMCA and 15.5% NB for FICOLL, significantly more 
residual biomaterial in BMCA (31.9%) than in FICOLL (19.7%), and a 
significantly smaller marrow space in BMCA (47.4%) than in FICOLL 
(64.8%).
The three RCTs included in the meta-analysis comprised two with 
a parallel-group design [17,19] and one with a split-mouth design [16]. 
In a randomized controlled split-mouth study, Rickert et al. 
[16] analysed histomorphometrically the percentage of NB in 12 
consecutive edentulous patients (48-69 years old) after performing 
bilateral maxillary sinus floor elevation. On one side the augmentation 
procedure was performed with BBM (Bio-Oss®, Geistlich Pharma) 
seeded with bone-marrow-aspirate autogenous bone cells harvested 
from the posterior iliac crest (test group), while on the contralateral 
side the augmentation procedures were performed with BBM mixed 
with autogenous bone that had been harvested from the retromolar 
area (control group), with the two sides allocated randomly. Biopsy 
samples were obtained after 13–16 weeks, and 66 implants were placed. 
One patient was excluded from the histological analysis because the 
biopsy sample of the control side was not obtained from an augmented 
site. The amount of NB formation was significantly greater in the test 
group (17.7 ± 7.3%) than in the control group (12.0 ± 6.6%). At 3 
months after sinus augmentation, the percentage of BBM present in the 
samples was comparable in the test and control groups. Histological 
analysis showed that NB lamellae surrounded the biomaterial particles 
and stabilized the graft complex. No signs of inflammatory reaction 
were observed. 
Sauerbier et al. [17] performed 45 two-stage sinus lift augmentation 
procedures in 26 of 40 randomized patients (38.9–67.7 years old). 
Thirty-four sinuses of 25 patients (test arm) were augmented with BBM 
(Bio-Oss®, Geistlich Pharma) in combination with pelvic bone-marrow 
concentrate aspirate, while 11 sinuses (control group) in 11 patients 
were grafted with a mixture of 70% BBM and 30% autologous bone 
harvested from the retromolar area. Each sinus was randomly assigned 
to either the test or control arm, and in 10 patients with a double sinus 
lift, the randomization resulted in a split-mouth model. Bone biopsy 
samples were obtained after a healing period of 3.41 ± 0.39 months at 
the time of implant insertion. The histological findings were similar in 
all of the specimens. No signs of inflammation were detected, vital bone 
tissue containing osteocytes inside the bone lacunae was observed, and 
the NB connected the biomaterial particles and stabilized the grafted 
complex. In a histomorphometric analysis the amount of NB formation 
did not differ significantly between the control (14.3 ± 1.8%) and test 
(12.6 ± 1.7%) groups. Cone-beam CT performed on 28 test and 9 control 
sinuses revealed that the volume of augmented bone was significantly 
greater in the test group (1.74 ± 0.69 mL) than in the control group 
(1.33 ± 0.62 mL). 
Hermund et al. [19] evaluated histologically the bone formation in 
two-stage sinus floor augmentation procedures, comparing the use of 
composite graft (BBM and autogenous bone harvested using a scraper) 
alone (control group) or supplemented with cultivated autogenous bone 
cells derived from the tuberosity area (test group). Twenty maxillary 
sinus lift procedures were carried out in 20 patients randomly assigned 
to the test group (10 patients, age 60.4 ± 11.2 years) or the control group 
(10 patients, age 58.5 ± 8.1 years).
Implants (n=39) were placed after 4 months, and bone biopsies 
were performed at the same time. All implants were osseointegrated 
and loaded. There were no remarkable differences between the bone 
specimens in the two groups. In biopsy specimens from caudal portions, 
the mostly woven and occasionally lamellar NB was in contact with 
the BBM particles, which occasionally were completely incorporated 
within the new osseous tissue. In contrast, only a small amount of NB 
was found in the more apical aspects, where the biomaterial was mostly 
embedded within fibrovascular connective tissue. 
The potential risks of bias in the studies included in the meta-
analysis are summarized in Figure 2. Two trials [16,19] were judged to 
be at low risk of bias, whereas one [17] was judged to be at high risk 
of bias due to the specific study design used. This meta-analysis found 
insufficient evidence for determining whether there was a difference in 
NB formation after sinus floor augmentation performed with BBM or 
BBM and stem cells (Figure 3).
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Discussion
The purpose of this review was to determine the clinical and 
histological performances of different mesenchymal cell-scaffold 
constructs used for oral bone regeneration in human subjects. 
The systematic search revealed a paucity of publications and high 
heterogeneity among the various studies. Indeed, while there have been 
numerous in vitro and animal studies of engineered stem-cell scaffolds, 
few researches have involved human subjects, probably due to the 
difficulty of obtaining consent from the relevant ethics committees. 
Moreover, the lack of blinding and randomization, and differences 
between model protocols, study designs, the included human and 
cellular populations, and surgical techniques made it difficult to 
compare the results and draw significant conclusions. 
This review found that the most commonly used surgical procedure 
for testing the outcome of tissue-engineered scaffolds is the two-stage 
sinus lift [9,20]. This procedure is a good clinical model for evaluating 
bone regeneration, because bone formation occurs within an enclosed 
space, and hence with a minimal interference from external factors 
[17]. In addition, the two-stage sinus lift procedure is more predictable 
than vertical bone regeneration and allows bone biopsy specimens to 
Figure 2: Risk of bias summary: review authors' judgements about each risk of 
bias item for each included study.
Figure 3: Forest plot of comparison: BBM versus BBM and stem cell.
be collected during implant insertion, thereby avoiding any additional 
discomfort for the patients [24].
While many different materials for promoting bone regeneration 
have been tested, none of them has satisfied all of the requirements 
for an ideal scaffold. Based on the current literature, an ideal scaffold 
should maintain an adequate 3D shape after implantation, facilitate cell 
adhesion and proliferation, promote cell growth, and be mechanically 
strong [1,3,24-26]. Furthermore, it should be biocompatible, biodegrade 
into no toxic by-products, easily handled and easily processed during 
manufacture. The scaffold should have an appropriate macrostructure 
(in terms of the surface geometry and a porous structure with a pore 
size of 100–700 μm2) and microstructure to induce cell attachment, 
and an adequate molecular structure to induce specific tissue responses 
[1,3,24-26]. Finally, it should exhibit osteoinductive/osteoconductive 
properties and a resorption time compatible with tissue regeneration 
[1]. No ideal scaffold has yet been developed, and the evidence for the 
use of different investigated materials remains controversial.
The three included studies [15,20,22] that used an allogenic graft as 
a scaffold for mesenchymal stem cells produced encouraging findings 
in terms of NB formation. However, it is impossible to compare their 
results due to differences in the types of allograft, sources of stem cells, 
laboratory procedures, surgical interventions and methods used to 
analyze NB. Indeed, the properties of allografts change significantly 
during decellularization, sterilization and storage processes. When 
the method of processing removes the viable cells (osteogenic and 
osteoinductive) and leaves the extracellular matrix (osteoconductive), 
the allograft is osteoconductive, whereas when leaving factors such 
as bone morphogenetic proteins and transforming growth factor-β, 
the demineralized bone matrix can be osteoinductive and able to 
recruit mesenchymal stem cells and stimulate their differentiation into 
osteoprogenitor cells [1]. 
PLGA scaffold is a widely investigated biomaterial in bone 
regeneration [2,9,12,14,18,27,28], although the few studies that 
have investigated its utility as a scaffold in tissue engineering have 
produced conflicting results. Insufficient clinical success in the sinus 
lift procedures due to poor efficacy in promoting cellular activity 
and bone regeneration was reported by Mangano [12] and Voss [14], 
whereas good clinical and radiologic results were found in the studies 
of Trautvetter [18] and Shimming [9]. Insufficient bone regeneration 
and a high resorption rate have been reported when two-stage sinus 
lift procedures were performed with stem cells and PLGA scaffolds 
[9,14,18,27,28]. Augmentation failure could be caused by the supply 
of oxygen and nutrients being insufficient to sustain the survival and 
proliferation of cells embedded within a large polymer construct, and 
the low pH produced by polymer resorption, which could prevent 
the survival of osteoblasts. Furthermore, an increase in fibrous tissue 
encapsulation during healing might be due to foreign-body reactions 
to acidic polymer degradation products induced by the hydrolysis of 
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PLGA bulk erosion in vivo [1]. Therefore, such tissue-engineered bone 
should be used only in sinus lift procedures with simultaneous implant 
placement and at sites that provide sufficient bone. 
Major advantages have been reported when using collagen sponge 
scaffolds, including biocompatibility, biodegradability and the ability to 
bind growth factors critical for osteoconduction [10,21,23]. A tissue-
engineered combination of a collagen matrix with autologous cells, 
derived from periosteum or dental pulp, tested in two of the included 
studies, was shown to be capable of creating NB tissue and exhibit a 
high mineralization rate. However, the reported data relate to small 
numbers of procedures and patients and short observation periods, and 
so they must be considered with extreme caution [10,21,23,28]. 
BBM is one of the most-used and well-studied grafting materials in 
bone reconstructive procedures. BBM exhibits excellent osteoconductive 
properties due to its morphological structure and mineral composition, 
which are similar to those of human cancellous bone, and its widespread 
interconnecting pore system promotes angiogenesis and the migration 
of osteogenic cells [29]. 
The present review found that more studies have investigated 
the use of BBM as a scaffold construct with mesenchymal cells. The 
availability of three RCTs made it possible to perform a meta-analysis, 
but this found that the available evidence is insufficient for determining 
whether NB formation after sinus floor augmentation differed 
between using BBM or BBM and stem cells. Indeed, the results were 
contradictory. Rickets et al. [16] reported an improved bone formation 
when the biomaterial was mixed with stem cells, whereas other studies 
found that the addition of autogenous stem cells to a graft of BBM 
[11,17] or to a composite graft of BBM and autogenous bone [19] did 
not exert statistically significant effects on the amount of NB formed.
Conclusions
The results of the present review should be interpreted with caution 
since few studies have histologically evaluated the performance of 
mesenchymal cell-scaffold constructs in human oral reconstructive 
procedures. The very small amount of available data makes it impossible 
to draw firm conclusions regarding any increase in bone formation 
achieved by using graft materials engineered with autogenous stem 
cells.
Further well-designed trials involving larger samples and longer 
follow-up periods are required to improve the level of evidence in order 
to understand whether mesenchymal cell-scaffold constructs offer 
significant long-term benefits to patients.
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